Johnson & Johnson MedTech has announced the U.S. launch of the VIRTUGUIDE™ System, following the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pre-operative Planning Software. This AI-powered, patient-matched solution is designed to simplify the Lapidus procedure, a type of bunion surgery. Early reports indicate that the system can reduce surgical time by 30 minutes compared to traditional methods. The VIRTUGUIDE™ System, developed in collaboration with PeekMed®, is now available in the U.S., marking a significant advancement in surgical precision for bunion deformities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via PR Newswire (Ref. ID: CL39120) on July 29, 2025, and is solely responsible for the information contained therein.